Lymphomatoid papulosis is a rare skin disorder. It is characterised by crops of self healing skin lesions. It is labeled by recurrent crops of pruritic papules at various stages of development which predominantly arise on the trunk and limbs. The papules heal voluntarily over 1-2 months, normally leaving slightly depressed oval scars. Lesions have unusual cells which are identical to those found in some lymphomas (cancers of the lymphatic system).

Many cases of lymphomatoid papulosis are benevolent, 10-20% of patients may have an associated lymphoma. This may be cutaneous T-cell lymphoma or an internal form of the disease. CD 30+ cutaneous T cell lymphomas appears clinically with single or few tumours or ulcers but with histologic characterstic of lymphomatoid papulosis. It is likely the CD 30+ lymphoproliferative disorders presenting a clinical and histologic aspect with lymphomatoid papulosis at one tail and T cell lymphoma on the other, with borderline cases at center. Genetic unsteadiness of tumor cells may result to altered expression of apoptotic proteins and immune-regulatory molecules, such as transforming growth factor-beta.

It may occur anywhere on the body but mostly affect the chest, stomach, back, arms and legs. Blisters willfully heal with or without leaving scars within 2-8 weeks of appearing. CD30 signaling is known to have an effect on the rise and survival of lymphoid cells. Papules appear in crops and can be little itchy. They may mature into blood or pus-filled lesions that break and form a crusty sore before healing completely. JunB is a possible target for experimental therapy in patients with these tumors. LyP may develop in any age, but the peak prevailes occurs in the fifth decade. Allelic form of the CD30 promoter microsatellite oppressive element was related with the growth of LyP, and the 30M362 allelic form was connected with progression to other CD30 + lymphomas in LyP patients. JunB, section of the AP-1 transcription factor complex complexed in cell proliferation and apoptosis, in virtually all CD30 + lymphomas.

Causes of Lymphomatoid Papulosis

Common causes of Lymphomatoid Papulosis

• Genetic predisposition.
• LyP lesions.
• T-cell lymphocytes (funny-looking white cells).

Symptoms of Lymphomatoid Papulosis

Common Symptoms of Lymphomatoid Papulosis

• Appetite loss.
• Fever.
• Anemia.
• Infections(low white count).
• Itchy
• Red patches.
• Swollen.
• Painless.
• Weight loss.
• Drenching night sweats.
• Lesions.

Treatment of Lymphomatoid Papulosis

Common Treatment of Lymphomatoid Papulosis

• Topical agents include glucocorticoids and carmustine (BCNU).
• Electron-beam irradiation has been employed as well.
• PUVA may control the disease but does not affect the long-term prognosis.
• Tetracyclines, sulfones, systemic glucocorticoids, and even acyclovir have been reported as effective by some researchers.
• Cortisone ointments will sometimes help.
• Ultraviolet light treatment will help control lymphomatoid papulosis.
• Methotrexate is sometimes used to treat lymphomatoid papulosis.